SUSMED,Inc. (TYO:4263)
Japan · Delayed Price · Currency is JPY 628.00
+10.00 (1.62%)
Jun 4, 2026, 10:30 AM JST
SUSMED,Inc. Income Statement
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 274 | 462 | 342 | 530 | 316 | 115 | |
Revenue Growth (YoY) | -39.51% | 35.09% | -35.47% | 67.72% | 174.78% | 238.24% |
Cost of Revenue | 15 | 12 | 12 | 8 | 11 | 9 |
Gross Profit | 259 | 450 | 330 | 522 | 305 | 106 |
Selling, General & Admin | 516 | 477 | 452 | 394 | 309 | 190 |
Research & Development | 241 | 273 | 243 | 176 | 226 | 249 |
Operating Expenses | 757 | 750 | 695 | 570 | 535 | 439 |
Operating Income | -498 | -300 | -365 | -48 | -230 | -333 |
Other Non Operating Income (Expenses) | 3 | 5 | 8 | 4 | 12 | 60 |
EBT Excluding Unusual Items | -495 | -295 | -357 | -44 | -218 | -273 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -4 |
Asset Writedown | -3 | -4 | -2 | -5 | -15 | - |
Other Unusual Items | 16 | 2 | 3 | - | - | - |
Pretax Income | -482 | -297 | -356 | -49 | -233 | -277 |
Income Tax Expense | 3 | 1 | 1 | 1 | - | - |
Net Income | -485 | -298 | -357 | -50 | -233 | -277 |
Net Income to Common | -485 | -298 | -357 | -50 | -233 | -277 |
Shares Outstanding (Basic) | 17 | 17 | 17 | 16 | 15 | 13 |
Shares Outstanding (Diluted) | 17 | 17 | 17 | 16 | 15 | 13 |
Shares Change (YoY) | 0.37% | 0.60% | 1.77% | 11.71% | 14.76% | 11.19% |
EPS (Basic) | -28.81 | -17.75 | -21.39 | -3.05 | -15.87 | -21.65 |
EPS (Diluted) | -28.81 | -17.75 | -21.39 | -3.05 | -15.87 | -21.65 |
Free Cash Flow | - | -436 | -233 | 94 | -177 | - |
Free Cash Flow Per Share | - | -25.96 | -13.96 | 5.73 | -12.05 | - |
Gross Margin | 94.53% | 97.40% | 96.49% | 98.49% | 96.52% | 92.17% |
Operating Margin | -181.75% | -64.94% | -106.73% | -9.06% | -72.78% | -289.56% |
Profit Margin | -177.01% | -64.50% | -104.39% | -9.43% | -73.73% | -240.87% |
Free Cash Flow Margin | - | -94.37% | -68.13% | 17.74% | -56.01% | - |
EBITDA | -489.5 | -293 | -360 | -43 | -228 | - |
EBITDA Margin | -178.65% | -63.42% | -105.26% | -8.11% | -72.15% | - |
D&A For EBITDA | 8.5 | 7 | 5 | 5 | 2 | - |
EBIT | -498 | -300 | -365 | -48 | -230 | -333 |
EBIT Margin | -181.75% | -64.94% | -106.73% | -9.06% | -72.78% | -289.56% |